prognostic indicators

Human epidermal growth factor receptor 2 may be a potential marker of poor prognosis in patients with unclassified ovarian cancer, according to a recent meta-analysis.
A recent study examined whether the Lung Immune Prognostic Index was associated with resistance to immunotherapy in patients with advanced non-small cell lung cancer.
Higher scores on a multi-biomarker disease activity system are associated with hospital infection, myocardial infarction, and coronary heart disease events in older patients with rheumatoid arthritis.
A recent study identified patient characteristics that help predict poor 3-year survival in newly diagnosed standard-risk multiple myeloma.
High levels of a specific enzyme are linked with lower survival rates in patients with multiple myeloma, according to a new study.
Upregulation of a specific protein may be an indicator of radiation resistance in patients with resected non-small cell lung cancer who received radiotherapy.
Prognosis and cure perceptions among older adults with acute myeloid leukemia often diverge from oncologist estimates.
Elevated C-reactive protein prior to autologous stem cell transplantation identifies a high-risk population in patients with multiple myeloma.
Maintenance therapy with a specific drug is associated with superior OS and PFS in patients who receive high-dose therapy followed by ASCT for MCL.
Results of a recent study showed that the prognostic implications of patient-specific and tumor biological features vary significantly across age-groups of patients with multiple myeloma.